XOMA Corp (XOMA)
24.05
+0.71
(+3.04%)
USD |
NASDAQ |
Mar 28, 16:00
23.86
-0.19
(-0.79%)
After-Hours: 20:00
XOMA Cash from Investing (TTM): -0.711M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.711M |
September 30, 2023 | -21.47M |
June 30, 2023 | -26.94M |
March 31, 2023 | -22.46M |
December 31, 2022 | -20.22M |
September 30, 2022 | -10.97M |
June 30, 2022 | -18.00M |
March 31, 2022 | -18.00M |
December 31, 2021 | -26.50M |
September 30, 2021 | -20.70M |
June 30, 2021 | -13.71M |
March 31, 2021 | -13.71M |
December 31, 2020 | -0.209M |
September 30, 2020 | -0.009M |
June 30, 2020 | -13.00M |
March 31, 2020 | -19.00M |
December 31, 2019 | -19.30M |
September 30, 2019 | -19.30M |
June 30, 2019 | -21.31M |
March 31, 2019 | -15.31M |
December 31, 2018 | -15.01M |
September 30, 2018 | -14.99M |
June 30, 2018 | -0.008M |
March 31, 2018 | 0.793M |
December 31, 2017 | 1.606M |
Date | Value |
---|---|
September 30, 2017 | 1.566M |
June 30, 2017 | 2.212M |
March 31, 2017 | 1.456M |
December 31, 2016 | 0.612M |
September 30, 2016 | 5.534M |
June 30, 2016 | 4.87M |
March 31, 2016 | 4.644M |
December 31, 2015 | 4.45M |
September 30, 2015 | 4.454M |
June 30, 2015 | 9.349M |
March 31, 2015 | 19.50M |
December 31, 2014 | 19.68M |
September 30, 2014 | -5.318M |
June 30, 2014 | -10.38M |
March 31, 2014 | -0.711M |
December 31, 2013 | 18.84M |
September 30, 2013 | 15.55M |
June 30, 2013 | 10.24M |
March 31, 2013 | -21.97M |
December 31, 2012 | -42.02M |
September 30, 2012 | -19.35M |
June 30, 2012 | -14.16M |
March 31, 2012 | -2.964M |
December 31, 2011 | -3.304M |
September 30, 2011 | -2.648M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-26.94M
Minimum
Jun 2023
-0.009M
Maximum
Sep 2020
-16.04M
Average
-18.50M
Median
Cash from Investing (TTM) Benchmarks
Kinnate Biopharma Inc | 104.74M |
Societal CDMO Inc | -8.237M |
Zevra Therapeutics Inc | -28.04M |
Corcept Therapeutics Inc | 90.91M |
Sarepta Therapeutics Inc | -165.80M |